ISM012-042
ISM012-042 is an orally active PHD1 and PHD2 inhibitor with IC50 values of 1.9 and 2.5 nM, respectively. ISM012-042 (2.5 μM) can protect Caco-2 cells from DSS-induced barrier disruption. In lipopolysaccharide (LPS) -induced mouse bone marrow-derived dendritic cells (BMDC), ISM012-042 has anti-inflammatory effects and can dose-dependently reduce the expression of IL-12 subunit IL-12p35 and TNF. ISM012-042 restores intestinal barrier function and alleviates intestinal inflammation in various experimental colitis models. ISM012-042 can be used for intestinal mucosal repair and research into immune diseases[1].
Product Specifications
CAS Number
2924181-80-4
UNSPSC
12352005
Target
HIF/HIF Prolyl-Hydroxylase
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CC(C)(OC(N1CCN(C2=CC=C3C(C=NC(C(NCC4=CN=C(C#N)C=C4)=O)=C3O)=N2)CC1)=O)C
Molecular Formula
C25H27N7O4
Molecular Weight
489.53
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
5'-O-DMTr-2'-deoxy-5-iodouridine-3'-CED Phosphoramidite
5'-O-DMTr-2'-deoxy-5-iodouridine-3'-CED Phosphoramidite
5'-O-DMTr-2'-deoxy-5-iodouridine-3'-CED Phosphoramidite
5'-O-DMTr-2'-deoxy-5-iodouridine-3'-CED Phosphoramidite
5'-O-DMTr-2'-deoxy-5-iodouridine-3'-CED Phosphoramidite